Search results
Simtuzumab (GS-6624) in Treatment of Advanced Liver Fibrosis But Not Cirrhosis Secondary to NASH
… Double-Blind Phase Open Label Phase (optional) Trial Website: https://clinicaltrials.gov/show/NCT01672866 …
Last Modified:
A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications in Subjects With Early Decompensated Liver Cirrhosis
… tablets or placebo tablets every day for 24 weeks. Trial Website: https://clinicaltrials.gov/show/NCT01904409 …
Last Modified:
A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination with Sofosbuvir for the Treatment of Post-Liver Transplant Subjects with Chronic Hepatitis C
… throughout the study as well as efficacy data. Trial Website: https://clinicaltrials.gov/show/NCT02161939 …
Last Modified: